Abstract
Whole-body autoradioluminography (WBAL) has evolved as the preferred method for conducting tissue distribution studies that are required for regulatory filings of a new drug entity (DE) and for projecting tissue dosimetry in human mass balance studies. Four experiments were designed to assess WBAL utility using tritium as early as lead development in the drug discovery process. The objective of experiment 1 was to determine the minimum amount of tritium to administer to rats required for obtaining widespread distribution into most tissues at concentrations greater than quantification limits. Experiments 2, 3, and 4 were conducted to identify a tissue compartment responsible for observed triphasic pharmacokinetics, to characterize the distribution of a [3H]DE into brain tissue, and to compare tissue distribution patterns between two rat strains, respectively. The minimum amount of tritium necessary to investigate the tissue distribution of [3H]DE in rats was 865 μCi/kg. Results from experiments 2, 3, and 4 illustrated A) the identification of adipose as the tissue compartment responsible for an extended terminal elimination phase, B) sustained penetration of a DE into brain tissues for at least 24 h, and C) tissue distribution differences between two DEs of the same therapeutic class, respectively. These experiments exemplify the value of WBAL as a screening tool to assist with the selection of a drug candidate. WBAL utilization in drug discovery provides insightful data toward designing pharmacology and toxicology experiments. Substituting the use of tritium for carbon-14 is of crucial importance in drug discovery since [3H]DEs are more readily obtainable than [14C]DEs.
Footnotes
-
ABBREVIATIONS: WBA, whole-body autoradiography; WBAL, whole-body autoradioluminography; DE, drug entity; HPLC, high-performance liquid chromatography; TLC, thin layer chromatography; SD, Sprague-Dawley; SH, spontaneously hypertensive; STD, standard curve calibrator(s); CQCS, cryosection quality control sample(s); AUC, area under the curve; CNS, central nervous system; GIT, gastrointestinal tract.
- Received March 2, 2004.
- Accepted June 29, 2004.
- The American Society for Pharmacology and Experimental Therapeutics
DMD articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|